AI systems, biomedical models, decision support software, and future enterprise intelligence platforms.
Coming laterScalable infrastructure for pipelines, cloud execution, storage, orchestration, and high-performance computation.
Coming laterFuture clinical assays, diagnostic workflows, and validated molecular testing systems for healthcare use.
Coming laterHospital-facing reporting, workflow software, system integrations, and clinical data management platforms.
Coming laterScientific education, training programs, bioinformatics learning, and future institutional onboarding systems.
Coming laterHemaLignC is a software platform under Sogarjo Life Sciences focused on genomic and transcriptomic analysis for hematologic malignancies. It is designed to support fusion detection, lineage prediction, molecular subtype classification, variant interpretation, and structured clinical-style reporting.
Multi-caller analysis for identifying relevant gene fusions from sequencing data, with emphasis on hematologic malignancy workflows.
Integrated classification methods for assigning disease lineage using molecular signals derived from expression and related genomic data.
Transcriptome-driven subtype prediction for clinically relevant leukemia groups, with expansion toward broader hematologic disease applications.
Structured software output that converts complex molecular findings into clear, standardized, decision-ready reports.